30 participants
Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-28
- Start Date:
- 2026-10-31
- Completion:
- 2030-10-31
Conditions
- Classic Follicular Lymphoma
- Grade 1 Follicular Lymphoma
- Grade 2 Follicular Lymphoma
- Grade 3a Follicular Lymphoma
Interventions
- BIOLOGICAL
- PROCEDURE
- OTHER
No Results Yet